A systematic review of hepatitis B screening economic evaluations in low- and middle-income countries
Abstract Background Chronic hepatitis B infection is a significant cause of morbidity and mortality worldwide; low- and middle-income countries (LMICs) are disproportionately affected. Economic evaluations are a useful decision tool to assess costs versus benefits of hepatitis B virus (HBV) screenin...
Main Authors: | Cameron M. Wright, Lydia Boudarène, Ninh Thi Ha, Olivia Wu, Neil Hawkins |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-03-01
|
Series: | BMC Public Health |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12889-018-5261-8 |
Similar Items
-
Cost of treatment and consequences for chronic hepatitis B and C virus infection at a tertiary care hospital in Delhi
by: P Balasundaram, et al.
Published: (2020-01-01) -
Economic evaluation of HCV testing approaches in low and middle income countries
by: Jake R. Morgan, et al.
Published: (2017-11-01) -
Actualización sobre hepatitis viral: etiología, patogenia, diagnóstico microbiológico y prevención
by: Carmen Rodríguez Acosta
Published: (2000-12-01) -
Prevention of Viral Hepatitis
by: Neşe SALTOĞLU
Published: (2001-09-01) -
Costs of Treatment, Follow-Up, and Complications of Chronic Hepatitis B and Hepatitis C Infections
by: Fatma Banu Karahasanoğlu, et al.
Published: (2013-12-01)